COSMOS Pharmaceutical Future Growth
Future criteria checks 1/6
COSMOS Pharmaceutical is forecast to grow earnings and revenue by 7.2% and 7.5% per annum respectively while EPS is expected to grow by 7.2% per annum.
Key information
7.2%
Earnings growth rate
7.2%
EPS growth rate
Consumer Retailing earnings growth | 11.5% |
Revenue growth rate | 7.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
5/31/2025 | 959,914 | 27,218 | 8,354 | 50,975 | 10 |
5/31/2024 | 893,443 | 25,101 | 5,324 | 47,884 | 11 |
5/31/2023 | 825,250 | 23,618 | 1,234 | 45,576 | 11 |
11/30/2022 | 788,292 | 23,209 | -3,655 | 41,973 | N/A |
8/31/2022 | 772,127 | 23,393 | N/A | N/A | N/A |
5/31/2022 | 755,414 | 23,155 | -11,303 | 32,194 | N/A |
2/28/2022 | 743,612 | 22,030 | N/A | N/A | N/A |
11/30/2021 | 733,387 | 25,329 | -5 | 35,596 | N/A |
8/31/2021 | 726,672 | 25,909 | N/A | N/A | N/A |
5/31/2021 | 726,424 | 27,156 | 1,811 | 27,875 | N/A |
2/28/2021 | 733,223 | 28,777 | N/A | N/A | N/A |
11/30/2020 | 723,309 | 25,736 | 28,882 | 50,935 | N/A |
8/31/2020 | 709,064 | 23,876 | N/A | N/A | N/A |
5/31/2020 | 684,403 | 21,435 | 39,513 | 65,461 | N/A |
2/29/2020 | 653,527 | 20,217 | N/A | N/A | N/A |
11/30/2019 | 638,034 | 18,951 | 10,653 | 38,209 | N/A |
8/31/2019 | 622,103 | 19,349 | N/A | N/A | N/A |
5/31/2019 | 611,137 | 19,185 | 5,339 | 34,379 | N/A |
2/28/2019 | 597,715 | 18,966 | N/A | N/A | N/A |
11/30/2018 | 585,536 | 18,857 | 1,302 | 30,947 | N/A |
8/31/2018 | 572,807 | 17,880 | N/A | N/A | N/A |
5/31/2018 | 557,999 | 17,633 | 3,135 | 32,586 | N/A |
2/28/2018 | 542,936 | 17,510 | N/A | N/A | N/A |
11/30/2017 | 526,523 | 17,313 | 6,814 | 35,488 | N/A |
8/31/2017 | 514,880 | 18,239 | N/A | N/A | N/A |
5/31/2017 | 502,732 | 18,215 | 8,271 | 36,938 | N/A |
2/28/2017 | 490,037 | 15,812 | N/A | N/A | N/A |
11/30/2016 | 477,739 | 14,981 | 5,955 | 34,300 | N/A |
8/31/2016 | 463,517 | 13,679 | N/A | N/A | N/A |
5/31/2016 | 447,273 | 12,435 | N/A | 30,986 | N/A |
2/29/2016 | 433,328 | 12,738 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSMY.F's forecast earnings growth (7.2% per year) is above the savings rate (2%).
Earnings vs Market: CSMY.F's earnings (7.2% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: CSMY.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: CSMY.F's revenue (7.5% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: CSMY.F's revenue (7.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CSMY.F's Return on Equity is forecast to be high in 3 years time